Kerri Huber is Chief Operating Officer of TCP Analytical Holdings, LLC. Kerri is an operations executive with over 30 years of experience in the Specialty Chemicals and Pharmaceutical Industries. She has a proven history of success in cGMP implementation, new product development, process optimization, team building and leadership, continuous improvement, and supply chain management.
Kerri is a skilled communicator and leader with a reputation for forging strong business relationships and motivating cross-functional teams that meet and exceed business objectives. Kerri started her career at JT Baker (Proctor & Gamble) as a chemical process engineer. She worked for Avantor (Mallinckrodt, Tyco, Covidien) for the next 24 years directing the Operations, Manufacturing, Product Development, and Quality functions globally. Kerri became the Director of Manufacturing/Product Development for Biospectra, Inc.
Prior to joining TCP Analytical, Kerri was the Global Manufacturing Director for Radius Health, where she successfully provided leadership for all manufacturing activities and oversaw routine commercial and clinical manufacturing in an FDA regulated environment.
Kerri earned her MBA from Lehigh University. She also holds a BS in Chemical Engineering from Lehigh University.
EXPERIENCE
Radius Health
Biospectra, Inc.
Avantar
JT Baker (Proctor & Gamble)
EDUCATION
Lehigh University
MBA
Lehigh University
BS, Chemical Engineering
